Valuation: Thermo Fisher Scientific, Inc.

Capitalization 173B 147B 134B 127B 237B 16,320B 239B 1,594B 621B 7,839B 648B 635B 27,064B P/E ratio 2026 *
23x
P/E ratio 2027 * 19.8x
Enterprise value 204B 173B 158B 149B 279B 19,236B 281B 1,879B 732B 9,240B 764B 748B 31,901B EV / Sales 2026 *
4.26x
EV / Sales 2027 * 3.94x
Free-Float
83.28%
Yield 2026 *
0.4%
Yield 2027 * 0.42%
1 day-0.22%
1 week+0.06%
Current month-3.35%
1 month-9.98%
3 months-12.19%
6 months-21.07%
Current year-20.11%
1 week 456.36
Extreme 456.36
480.3
1 month 455.6
Extreme 455.6
538.4
Current year 455.6
Extreme 455.6
643.99
1 year 385.46
Extreme 385.46
643.99
3 years 385.46
Extreme 385.46
643.99
5 years 385.46
Extreme 385.46
672.34
10 years 139.07
Extreme 139.07
672.34
Manager TitleAgeSince
Chief Executive Officer 58 15/10/2009
Director of Finance/CFO 46 01/03/2026
President 47 01/03/2026
Director TitleAgeSince
Director/Board Member 68 09/11/2006
Chairman 58 26/02/2020
Director/Board Member 65 26/05/2009
Change 5d. change 1-year change 3-years change Capi.($)
-0.28%+0.06%+7.01%-12.63% 173B
-3.48%-3.09%-21.92%+44.46% 159B
-0.86%-2.78%-15.75%-26.69% 121B
-0.71%-6.17%-48.15%-0.09% 80.16B
-1.57%-5.47%+5.31%-11.28% 46.04B
+0.49%-3.10%-30.74%-37.24% 44.18B
-0.85%+15.98%-4.51%+30.17% 34.86B
-1.09%+1.56%-1.40%-10.76% 32.67B
+0.06%+1.31%-23.83%-44.48% 30.34B
-1.48%-2.22%-17.31%-13.27% 29.99B
Average -1.01%+0.10%-15.13%-8.18% 75.16B
Weighted average by Cap. -1.26%-1.07%-14.12%-2.06%

Financials

2026 *2027 *
Net sales 47.78B 40.59B 37.15B 35.06B 65.4B 4,512B 65.98B 441B 172B 2,167B 179B 175B 7,483B 50.41B 42.82B 39.19B 36.99B 69B 4,760B 69.61B 465B 181B 2,287B 189B 185B 7,894B
Net income 7.34B 6.24B 5.71B 5.39B 10.05B 694B 10.14B 67.73B 26.4B 333B 27.55B 26.97B 1,150B 8.25B 7.01B 6.42B 6.06B 11.29B 779B 11.39B 76.1B 29.67B 374B 30.95B 30.3B 1,292B
Net Debt 30.88B 26.24B 24.01B 22.66B 42.27B 2,916B 42.65B 285B 111B 1,401B 116B 113B 4,836B 25.99B 22.08B 20.21B 19.07B 35.57B 2,454B 35.89B 240B 93.43B 1,179B 97.49B 95.44B 4,070B
Logo Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (73.2%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - scientific analysis equipments (16.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.; - diagnostics equipment and products (10.1%). Net sales break down by source of revenue between sales of products (58.4%) and services (41.6%). Net sales break down geographically as follows: North America (52.5%), Europe (25.3%), Asia/Pacific (18.6%) and other (3.6%).
Employees
125,000
Date Price Change Volume
11/05/26 464.09 $ -0.20% 466,191
08/05/26 465.00 $ -1.99% 3,905,812
07/05/26 474.46 $ +0.32% 2,533,657
06/05/26 472.95 $ +1.33% 1,861,538
05/05/26 466.76 $ +0.90% 2,046,098
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
465.00USD
Average target price
620.12USD
Spread / Average Target
+33.36%

Quarterly revenue - Rate of surprise